Safer and more appropriate blood transfusion therapy

Makoto Handa

Research output: Contribution to journalArticle

Abstract

The risks associated with transfusion with blood components have been greatly reduced due to the implementation of innovative strategies for donor selection and testing, as well as safety measures such as universal prestorage leukocyte reduction. However, a variety of residual or unsolved risks, such as severe acute reaction of transfusion-related acute lung injury, transfusion-associated circulatory overload and transfusion-transmitted infections, remain. Patients with hematological disorders are at high risk, since they receive therapeutic interventions frequently requiring transfusion. Thereby, balancing risk and benefit for patients, hematologists should prescribe blood components through evidence-based decision-making, minimize unnecessary transfusions and then conduct safe and error-free transfusion with a standard procedure involving the transfusion process at the bedside.

Original languageEnglish
Pages (from-to)2170-2179
Number of pages10
Journal[Rinshō ketsueki] The Japanese journal of clinical hematology
Volume56
Issue number10
DOIs
Publication statusPublished - 2015 Oct 1

Fingerprint

Blood Transfusion
Blood Component Transfusion
Donor Selection
Acute Lung Injury
Decision Making
Leukocytes
Therapeutics
Safety
Infection
Transfusion Reaction

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Safer and more appropriate blood transfusion therapy. / Handa, Makoto.

In: [Rinshō ketsueki] The Japanese journal of clinical hematology, Vol. 56, No. 10, 01.10.2015, p. 2170-2179.

Research output: Contribution to journalArticle

@article{ea9f120bf8b44dc799805b867cc0ef7a,
title = "Safer and more appropriate blood transfusion therapy",
abstract = "The risks associated with transfusion with blood components have been greatly reduced due to the implementation of innovative strategies for donor selection and testing, as well as safety measures such as universal prestorage leukocyte reduction. However, a variety of residual or unsolved risks, such as severe acute reaction of transfusion-related acute lung injury, transfusion-associated circulatory overload and transfusion-transmitted infections, remain. Patients with hematological disorders are at high risk, since they receive therapeutic interventions frequently requiring transfusion. Thereby, balancing risk and benefit for patients, hematologists should prescribe blood components through evidence-based decision-making, minimize unnecessary transfusions and then conduct safe and error-free transfusion with a standard procedure involving the transfusion process at the bedside.",
author = "Makoto Handa",
year = "2015",
month = "10",
day = "1",
doi = "10.11406/rinketsu.56.2170",
language = "English",
volume = "56",
pages = "2170--2179",
journal = "[Rinshō ketsueki] The Japanese journal of clinical hematology",
issn = "0485-1439",
publisher = "Nihon Rinsho Ketsueki Gakkai/Japan Society of Clinical Hematology",
number = "10",

}

TY - JOUR

T1 - Safer and more appropriate blood transfusion therapy

AU - Handa, Makoto

PY - 2015/10/1

Y1 - 2015/10/1

N2 - The risks associated with transfusion with blood components have been greatly reduced due to the implementation of innovative strategies for donor selection and testing, as well as safety measures such as universal prestorage leukocyte reduction. However, a variety of residual or unsolved risks, such as severe acute reaction of transfusion-related acute lung injury, transfusion-associated circulatory overload and transfusion-transmitted infections, remain. Patients with hematological disorders are at high risk, since they receive therapeutic interventions frequently requiring transfusion. Thereby, balancing risk and benefit for patients, hematologists should prescribe blood components through evidence-based decision-making, minimize unnecessary transfusions and then conduct safe and error-free transfusion with a standard procedure involving the transfusion process at the bedside.

AB - The risks associated with transfusion with blood components have been greatly reduced due to the implementation of innovative strategies for donor selection and testing, as well as safety measures such as universal prestorage leukocyte reduction. However, a variety of residual or unsolved risks, such as severe acute reaction of transfusion-related acute lung injury, transfusion-associated circulatory overload and transfusion-transmitted infections, remain. Patients with hematological disorders are at high risk, since they receive therapeutic interventions frequently requiring transfusion. Thereby, balancing risk and benefit for patients, hematologists should prescribe blood components through evidence-based decision-making, minimize unnecessary transfusions and then conduct safe and error-free transfusion with a standard procedure involving the transfusion process at the bedside.

UR - http://www.scopus.com/inward/record.url?scp=84965141929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84965141929&partnerID=8YFLogxK

U2 - 10.11406/rinketsu.56.2170

DO - 10.11406/rinketsu.56.2170

M3 - Article

C2 - 26458457

AN - SCOPUS:84965141929

VL - 56

SP - 2170

EP - 2179

JO - [Rinshō ketsueki] The Japanese journal of clinical hematology

JF - [Rinshō ketsueki] The Japanese journal of clinical hematology

SN - 0485-1439

IS - 10

ER -